Placental Cells for Diabetic Foot Ulcers

Part of paid clinical trials in Winston-Salem, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT07686094
Phase
PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Placenta Stem Cells — DRUG
    Injection of 30 M placenta stem cells into/around the diabetic foot ulcer and along the anterior and posterior tibial arteries of the index leg.

Study Details

The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.

Key Dates

Start date
Oct 31, 2026
Status verified
Jun 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
12 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Diabetic with Foot Ulcer
    Type 2 diabetes mellitus with a non-healing (\> 4 weeks) unilateral diabetic foot ulcer despite standard of care treatment

Primary Outcome Measure

Number of Injection Sites Bleeding [ Time Frame: Month 1 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Atrium Health Wake Forest BaptistWinston-SalemNorth Carolina27157
Mary-Clare Day, RN
[email protected]
336-713-1343

Find similar trials in Winston-Salem, NC

By research site
Atrium Health Wake Forest Baptist· Winston-Salem, NC

Related Studies